Neisseria gonorrhoeae

Neisseria gonorrhoeae Overview

Neisseria gonorrhoeae often presents asymptomatically but can cause severe reproductive complications and has shown alarming antimicrobial resistance (CDC, 2024a). PCR detection enables timely, appropriate therapy and supports surveillance efforts (Workowski et al., 2021).

References

Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park I., Reno, H., Jonathan M. Zenilman J.M.,Bolan, G. A. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187. https://doi.org/10.15585/mmwr.rr7004a1

Products used to detect Neisseria gonorrhoeae

The STI large PCR panel is designed for multiplex in vitro assessment of 9 common microbiota typically associated with transmission by sexual activity, using real-time PCR.
The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.